Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-24 7:55 PM View:  | Calidi Biotherapeutics, Inc. (CLDI) | 21-Dec-23 | Grant | 5,644 | $1.80 | $10,159.20 | 4% 127.66K to 133.3K | |
| 06-Nov-23 12:38 PM View: | Cts Corp (CTS) | 02-Nov-23 | Grant | 3,600 | -- | -- | 14% 26.41K to 30.01K | |
| 28-Sep-23 5:08 PM View: | Syneos Health, Inc. (SYNH) | 28-Sep-23 | Disposition | 8,356 | $17.98 | $150,199.00 | (100%) 8.36K to 0 | |
| 30-May-23 9:19 PM View: | Syneos Health, Inc. (SYNH) | 25-May-23 | Grant | 4,863 | -- | -- | 139% 3.49K to 8.36K | |
| 14-Nov-22 3:24 PM View: | Cts Corp (CTS) | 10-Nov-22 | Grant | 3,100 | -- | -- | 13% 23.31K to 26.41K | |
| 27-May-22 5:13 PM View: | Syneos Health, Inc. (SYNH) | 25-May-22 | Grant | 2,839 | -- | -- | 434% 0.65K to 3.49K | |
| 20-Jan-22 5:13 PM View: | Syneos Health, Inc. (SYNH) | 18-Jan-22 | Grant | 654 | -- | -- | 100% 0 to 0.65K | |
| 05-Nov-21 2:52 PM View: | Cts Corp (CTS) | 04-Nov-21 | Grant | 3,600 | $36.69 | $132,084.00 | 18% 19.71K to 23.31K | 0% |
| 10-Feb-21 8:53 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 29,037 | $205.77 | $5,974,940.00 | 89% 32.58K to 61.61K | (2%) |
| 03-Feb-21 7:26 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Payment of Exercise | 7,490 | $207.97 | $1,557,700.00 | (19%) 40.07K to 32.58K | |
| 03-Feb-21 7:26 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Option Exercise | 16,754 | -- | -- | 72% 23.31K to 40.07K | |
| 06-Nov-20 4:24 PM View: | Cts Corp (CTS) | 05-Nov-20 | Grant | 4,200 | $29.23 | $122,766.00 | 27% 15.51K to 19.71K | 16% |
| 13-Jul-20 1:43 PM View: | Eli Lilly & Co. (LLY) | 09-Jul-20 | Market Sale (Planned) | 11,000 | $170.00 | $1,870,000.00 | (32%) 34.27K to 23.27K | 3% |
| 18-Jun-20 9:36 AM View: | Eli Lilly & Co. (LLY) | 16-Jun-20 | Market Sale (Planned) | 17,000 | $162.94 | $2,770,000.00 | (33%) 51.27K to 34.27K | (1%) |
| 09-Jun-20 4:52 PM View: | Eli Lilly & Co. (LLY) | 05-Jun-20 | Market Sale (Planned) | 10,000 | $150.00 | $1,500,000.00 | (16%) 61.27K to 51.27K | (10%) |
| 13-Mar-20 11:02 AM View: | Cts Corp (CTS) | 13-Mar-20 | Market Purchase | 940 | $22.17 | $20,839.80 | 8% 12.07K to 13.01K | 53% |
| 13-Mar-20 11:02 AM View: | Cts Corp (CTS) | 12-Mar-20 | Market Purchase | 863 | $21.59 | $18,632.20 | 8% 11.21K to 12.07K | 57% |
| 13-Mar-20 11:02 AM View: | Cts Corp (CTS) | 11-Mar-20 | Market Purchase | 860 | $23.45 | $20,167.00 | 8% 10.35K to 11.21K | 44% |
| 10-Mar-20 4:09 PM View: | Cts Corp (CTS) | 10-Mar-20 | Market Purchase | 850 | $23.51 | $19,983.50 | 9% 9.5K to 10.35K | 44% |
| 10-Mar-20 4:09 PM View: | Cts Corp (CTS) | 09-Mar-20 | Market Purchase | 900 | $22.19 | $19,971.00 | 10% 8.6K to 9.5K | 52% |
| 13-Feb-20 6:25 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 18,322 | -- | -- | 43% 42.91K to 61.23K | |
| 04-Feb-20 3:59 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-20 | Payment of Exercise | 7,299 | $139.64 | $1,019,230.00 | (15%) 50.21K to 42.91K | (17%) |
| 04-Feb-20 3:59 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-20 | Option Exercise | 16,317 | -- | -- | 48% 33.89K to 50.21K | |
| 09-Dec-19 4:37 PM View: | Eli Lilly & Co. (LLY) | 06-Dec-19 | Market Sale (Planned) | 4,500 | $120.00 | $540,000.00 | (12%) 38.4K to 33.9K | (36%) |
| 08-Nov-19 9:33 AM View: | Cts Corp (CTS) | 07-Nov-19 | Grant | 4,400 | $27.81 | $122,364.00 | 105% 4.2K to 8.6K | 21% |
| 23-Sep-19 3:54 PM View: | Eli Lilly & Co. (LLY) | 20-Sep-19 | Market Sale (Planned) | 4,500 | $117.00 | $526,500.00 | (10%) 42.87K to 38.37K | (39%) |
| 04-Sep-19 3:09 PM View: | Eli Lilly & Co. (LLY) | 03-Sep-19 | Market Sale (Planned) | 19,500 | $112.91 | $2,201,740.00 | (31%) 62.37K to 42.87K | (44%) |
| 16-Apr-19 2:48 PM View: | Eli Lilly & Co. (LLY) | 12-Apr-19 | Market Sale (Planned) | 10,000 | $124.65 | $1,246,500.00 | (14%) 72.32K to 62.32K | (30%) |
| 06-Feb-19 7:58 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 21,224 | $120.17 | $2,550,490.00 | 42% 51.07K to 72.3K | 36% |
| 05-Feb-19 7:09 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Payment of Exercise | 4,364 | $119.86 | $523,069.00 | (8%) 55.44K to 51.07K | (36%) |
| 05-Feb-19 7:09 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Option Exercise | 9,722 | -- | -- | 21% 45.72K to 55.44K | |
| 04-Feb-19 4:32 PM View: | Eli Lilly & Co. (LLY) | 31-Jan-19 | Market Sale (Planned) | 4,000 | $120.00 | $480,000.00 | (8%) 49.72K to 45.72K | (36%) |
| 09-Nov-18 5:16 PM View: | Cts Corp (CTS) | 08-Nov-18 | Grant | 4,200 | $28.85 | $121,170.00 | 100% 0 to 4.2K | 17% |
| 05-Oct-18 2:08 PM View: | Eli Lilly & Co. (LLY) | 04-Oct-18 | Market Sale (Planned) | 7,000 | $114.64 | $802,480.00 | (12%) 56.7K to 49.7K | (42%) |
| 19-Sep-18 5:47 PM View: | Eli Lilly & Co. (LLY) | 18-Sep-18 | Market Sale (Planned) | 3,000 | $107.00 | $321,000.00 | (5%) 59.7K to 56.7K | (52%) |
| 19-Sep-18 5:47 PM View: | Eli Lilly & Co. (LLY) | 17-Sep-18 | Market Sale (Planned) | 3,000 | $105.61 | $316,830.00 | (5%) 62.7K to 59.7K | (54%) |
| 05-Feb-18 6:33 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Payment of Exercise | 7,133 | $81.45 | $580,983.00 | (10%) 69.75K to 62.62K | (96%) |
| 05-Feb-18 6:33 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Option Exercise | 15,993 | -- | -- | 30% 53.76K to 69.75K | |
| 31-Jan-18 6:15 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 9,316 | $87.60 | $816,082.00 | 21% 44.44K to 53.76K | 82% |
| 05-Dec-17 5:35 PM View: | Eli Lilly & Co. (LLY) | 04-Dec-17 | Market Sale (Planned) | 3,532 | $86.00 | $303,752.00 | (7%) 47.97K to 44.44K | (85%) |
| 13-Nov-17 12:55 PM View: | Eli Lilly & Co. (LLY) | 10-Nov-17 | Market Sale (Planned) | 2,003 | $83.67 | $167,591.00 | (4%) 49.95K to 47.95K | (89%) |
| 08-Feb-17 10:02 AM View: | Eli Lilly & Co. (LLY) | 06-Feb-17 | Market Sale | 15,000 | $77.66 | $1,164,900.00 | (23%) 64.87K to 49.87K | (105%) |
| 03-Feb-17 3:20 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Payment of Exercise | 3,127 | $77.03 | $240,873.00 | (5%) 68.0K to 64.87K | (107%) |
| 03-Feb-17 3:20 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Option Exercise | 6,659 | -- | -- | 11% 61.34K to 68.0K | |
| 31-Jan-17 6:34 PM View: | Eli Lilly & Co. (LLY) | 27-Jan-17 | Grant | 13,150 | $75.38 | $991,247.00 | 27% 48.19K to 61.34K | 112% |
| 27-Jan-17 10:00 PM View: | Eli Lilly & Co. (LLY) | 16-Dec-16 | Gift | 1,200 | -- | -- | (2%) 49.39K to 48.19K | |
| 28-Apr-16 3:43 PM View: | Eli Lilly & Co. (LLY) | 27-Apr-16 | Market Sale | 12,000 | $76.27 | $915,240.00 | (20%) 61.3K to 49.3K | (113%) |
| 02-Feb-16 3:32 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-16 | Market Sale | 5,000 | $78.75 | $393,750.00 | (8%) 66.27K to 61.27K | (108%) |
| 28-Jan-16 6:57 PM View: | Eli Lilly & Co. (LLY) | 26-Jan-16 | Grant | 7,035 | $81.96 | $576,589.00 | 12% 59.23K to 66.27K | 100% |
| 23-Nov-15 3:45 PM View: | Eli Lilly & Co. (LLY) | 20-Nov-15 | Payment of Exercise | 9,674 | $83.72 | $809,907.00 | (14%) 68.89K to 59.21K | (96%) |